Nerve Tape: a quick, snap-on repair aid for injured nerves
Official title: Commercialization Readiness for Nerve Tape: a nerve repair coaptation aid
Funded at Biocircuit Technologies, INC. · NIH-11511974 · Data updated 2026-11-12
A small, easy-to-use device helps doctors quickly repair severed nerves without traditional sutures, aiming to reduce surgical time and improve outcomes for people with nerve injuries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biocircuit Technologies, INC. NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 22, 2023 |
| Project end | November 30, 2026 |
| Funding year | 2026 |
| Award (this year) | $240,127 |
| NIH project number | 5SB1NS137879-03 |
| Project ID | NIH-11511974 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults with acute or recent nerve injuries where surgical repair is considered.
✕Less likely to help
Patients not requiring nerve repair or those outside the device’s intended use may not benefit.
What this research studies
This project aims to bring Bio-Circuit Technologies’ Nerve Tape device to market as a simple alternative to microsuture nerve repair. It focuses on validating the device’s safety and performance for clinical use and preparing for regulatory clearance. The effort includes testing materials, design transfers, and steps needed to launch the product for patients who have nerve injuries. If successful, surgeons could use the device to align nerve ends quickly and securely during repair. The goal is to provide a more consistent, faster option that could improve recovery for patients with nerve damage.
Why it matters
Potential benefit: If successful, patients with nerve injuries could benefit from faster, easier repairs and potentially better functional recovery.
How similar studies have gone: This SBIR effort builds on prior device concepts and seeks regulatory clearance for a new biologic-material version; success depends on additional testing and validation.
Where this research is happening
-
Biocircuit Technologies, INC.
Atlanta, United States Active
Researchers
- Principal investigator: Clements, Isaac Perry — Biocircuit Technologies, INC.
- Study coordinator: Clements, Isaac Perry
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.